OncoImmune

OverviewSuggest Edit

OncoImmune is a clinical-stage biopharmaceutical company. It is engaged in the discovery and development of biopharmaceuticals for the treatment of cancer and autoimmune disease.
TypePrivate
Founded2000
HQRockville, MD, US
Websiteoncoimmune.com

Latest Updates

Employees (est.) (Mar 2020)9
Cybersecurity ratingBMore

Key People/Management at OncoImmune

Yang Liu

Yang Liu

Founder, President and Chief Scientific Officer, Chairman
Karen Qianye Liu

Karen Qianye Liu

Director
Gary Fanger

Gary Fanger

Director
Miao Hong

Miao Hong

Director
Pan Zheng

Pan Zheng

Founder, Senior Vice President and Chief Medical Officer
Martin Devenport

Martin Devenport

Chief Operating Officer
Show more

OncoImmune Office Locations

OncoImmune has an office in Rockville
Rockville, MD, US (HQ)
9430 Key W Ave #113
Show all (1)

OncoImmune Financials and Metrics

Summary Metrics

Founding Date

2000

OncoImmune total Funding

$71.8 m

OncoImmune latest funding size

$56 m

Time since last funding

a year ago

OncoImmune investors

OncoImmune's latest funding round in September 2020 was reported to be $56 m. In total, OncoImmune has raised $71.8 m
Show all financial metrics

OncoImmune Cybersecurity Score

Cybersecurity ratingPremium dataset

B

87/100

SecurityScorecard logo

OncoImmune Online and Social Media Presence

Embed Graph

OncoImmune News and Updates

Merck acquires OncoImmune to ramp supply of promising Covid drug

The medicine, referred to as CD24Fc, was shown to reduce the risk of respiratory failure or death by more than 50% in patients hospitalized with Covid-19 and requiring oxygen

HMCapital co-leads $56m Series B in US pharma firm OncoImmune

GBA Fund, GF Xinde, 3E Bioventures Capital, and Kaitai Capital also invested. The post HMCapital co-leads $56m Series B in US pharma firm OncoImmune appeared first on DealStreetAsia.

OncoImmune Frequently Asked Questions

  • When was OncoImmune founded?

    OncoImmune was founded in 2000.

  • Who are OncoImmune key executives?

    OncoImmune's key executives are Yang Liu, Karen Qianye Liu and Gary Fanger.

  • How many employees does OncoImmune have?

    OncoImmune has 9 employees.

  • Who are OncoImmune competitors?

    Competitors of OncoImmune include Jiangsu Hansoh Pharmaceutical Group, 3sbio and Pharmacyclics.

  • Where is OncoImmune headquarters?

    OncoImmune headquarters is located at 9430 Key W Ave #113, Rockville.

  • Where are OncoImmune offices?

    OncoImmune has an office in Rockville.

  • How many offices does OncoImmune have?

    OncoImmune has 1 office.